Search Results
Results found for "Luke Pattison"
- GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth
studies of opioid receptors, the challenge of peptide-binding GPCRs, and why understudied receptors like It felt like we were chatting over coffee — and hoping this becomes a reality in the future." — Anita
- Newly launched antibody libraries put hard-to-drug targets within reach
Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics The drugs also target relatively low-hanging fruit: like cytokines or tyrosine kinase receptors. To target hard-to-drug targets like G protein-coupled receptors (GPCRs), more libraries, including better
- Structural landscape of the Chemokine Receptor system
Mode – from CRS1 to CRS3 Chemokines possess a conserved tertiary structure known as the interleukin 8-like agonist ligands (CCL5, CCL3, and [6P4]CCL5) bind to the 7TM cavity with their N-termini adopting a hook-like constitutively active receptors, meaning they can signal independently of agonist (Casarosa, Bakker et al. 2001, Luker recycling of chemokines without activating G-protein pathways (Randolph-Habecker, Rahill et al. 2002, Luker
- From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit
trajectory in motion, culminating in a scalable, multiplexed platform to investigate GPCR-RAMP biology  like
- Ben Clements on Rescuing Opioids with GPCR Modulators
Neuropathic conditions like neuromas often resist standard opioid treatments.
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Drug-Like Properties: The Real Starting Point PK does not begin at dosing—it begins with physicochemical scaffold design through population modeling— correlates with clinical success Scientists need to “think like
- đź“° GPCR Weekly News, April 8 to 14, 2024
Chemically Diverse "Superscaffold" Library Enables Ligand Discovery for a Key GPCR Target Gunnar Schulte, Lukas If you have any research you would like to showcase to our community, you can submit a poster presentation
- Early Stage Biotech Hiring: What Really Holds a Team Together When the Science Starts to Drift
. 👉 Strong resumes feel like protection against uncertainty. What Survival Traits Look Like in Real Biotech Work 👉 When founders start paying attention, they realize In teams working on complex biology like GPCR targets, this kind of drift is not unusual.
- đź“° GPCR Weekly News, September 11 to 17, 2023
Robert Lefkowitz on his 50 years at Duke. Congratulations. Dr. basis of GPR84 signaling Structural diversity of leukotriene G-protein coupled receptors Industry News Duke Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- Episode 86 of the Dr. GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available!
📹Would you like to see the video? Subscribe to a Dr.
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Celtarys Research , leaders from academia and biotech unpack what effective collaboration really looks like 👉 Access this week’s full Premium Edition here ➤ Voice of the Community “It’s like being at a GPCR
- Trainees, this is for you...
Would you like to develop your presentation skills? Give a talk or present a poster at the Dr.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Targeting G Protein-Coupled Receptors Olfactive Biosolutions Establishes Scientific Advisory Board GLP-1s like signaling-competent receptors GPCRs in Neuroscience Astrocyte Gi-GPCR signaling corrects compulsive-like
- Four Reasons to Measure GPCR Signaling Bias in Drug Discovery
Another example is at the angiotensin AT1 receptor, biased ligands like TRV120027 block deleterious vasoconstriction assays distinguishes molecules that are genuinely different on a molecular level, and therefore more likely Standard angiotensin receptor blockers like losartan address this, but at the cost of eliminating beneficial
- GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...
Here, we show that human GPR125 likely undergoes cis-autoproteolysis when expressed in canine kidney The recruitment likely requires the C-terminal PDZ-domain-binding motif of GPR125 and its interaction
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
He’s focused on RGS proteins , pain comorbidities  like addiction and depression, and pushing for more
- Fly casting with ligand sliding and orientational selection supporting complex formation of a GPCR..
The deepest basin in the resultant free-energy landscape was assigned to native-like complex conformation Eventually, the native-like complex is completed.
- Why Fundraising Mistakes Kill Strong Biotech Startups
In early-stage biotech, fundraising rarely feels like a strategic threat. It feels like a necessary distraction. Strategic debate is compressed into slide-friendly conclusions. 👉 What looks like alignment is often
- đź“° GPCR Weekly News, February 19 to 25, 2024
We would like to extend our heartfelt thanks to Dr. determines temperature acclimatization of Caenorhabditis elegan Species-Specific Duplicated FMRFaR-like homogeneous assay for monitoring GPCR-mediated cAMP modulation and PDE activity GPCRs in the round: SMA-like
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Ways Schild plots reveal hidden complexities like allosterism and receptor heterogeneity. Deviations—like reduced maximal responses or non-linear regressions—signal confounding kinetics, receptor
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
Whether you’d like to partner, teach, share tools and technologies, or simply offer feedback , your input From free resources like the podcast and blog to our Premium ecosystem and Foundry initiatives, our mission
- Phospholipid Scrambling by G Protein-Coupled Receptors
The transport proteins that facilitate this process are classified as pump-like flippases and floppases and channel-like scramblases.
- đź“° GPCR Weekly News, May 29 to June 4, 2023
This week, we would like to highlight two new publications: Pharmacological hallmarks of allostery at If you'd like to showcase your work, please email us at Hello@DrGPCR.com. We would also like to take a moment to thank the organizers for inviting Dr.
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
I would like to take this opportunity to thank all our French partners who trust us in the generation
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Discover how factors like restricted tissue diffusion and receptor density can dramatically alter drug Why contribute: Join a global, like-minded GPCR community.
- đź“° GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
member , you’re also unlocking over 500 minutes of exclusive, expert-led content from thought leaders like Don’t miss out on insightful resources like '  Applying Pharmacology to Drug Discovery ' and ' Advanced
- GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between ...
The molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated A greater understanding of this function of GPCRs is likely to significantly augment our ability to further
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties
- Understanding Orthosteric Binding: The Key to Drug Action
By considering factors like the Langmuir adsorption isotherm and binding curves, researchers can better



















